MTNB icon

Matinas BioPharma
MTNB

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $7.01M invested in Matinas BioPharma in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.78M
2
+$1.16M
3
+$925K
4
Millennium Management
Millennium Management
New York
+$854K
5
Goldman Sachs
Goldman Sachs
New York
+$614K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.78M
2
$1.16M
3
$925K
4
$854K
5
$614K
6
$300K
7
$221K
8
$193K
9
$166K
10
$105K
11
$103K
12
$98K
13
$97K
14
$96K
15
$95.6K
16
$67K
17
$66K
18
$58K
19
$10K